131 related articles for article (PubMed ID: 36252395)
1. Development and preclinical evaluation of [
Vercouillie J; Buron F; Sérrière S; Rodrigues N; Gulhan Z; Chartier A; Chicheri G; Marzag H; Oury A; Percina N; Bodard S; Ben Othman R; Busson J; Suzenet F; Guilloteau D; Marchivie M; Emond P; Routier S; Chalon S
Eur J Med Chem; 2022 Dec; 244():114794. PubMed ID: 36252395
[TBL] [Abstract][Full Text] [Related]
2. In vivo imaging of human cholinergic nerve terminals with (-)-5-(18)F-fluoroethoxybenzovesamicol: biodistribution, dosimetry, and tracer kinetic analyses.
Petrou M; Frey KA; Kilbourn MR; Scott PJ; Raffel DM; Bohnen NI; Müller ML; Albin RL; Koeppe RA
J Nucl Med; 2014 Mar; 55(3):396-404. PubMed ID: 24481024
[TBL] [Abstract][Full Text] [Related]
3. 3D QSAR study, synthesis, and in vitro evaluation of (+)-5-FBVM as potential PET radioligand for the vesicular acetylcholine transporter (VAChT).
Kovac M; Mavel S; Deuther-Conrad W; Méheux N; Glöckner J; Wenzel B; Anderluh M; Brust P; Guilloteau D; Emond P
Bioorg Med Chem; 2010 Nov; 18(21):7659-67. PubMed ID: 20889347
[TBL] [Abstract][Full Text] [Related]
4. Distribution of cholinergic nerve terminals in the aged human brain measured with [
Okkels N; Horsager J; Labrador-Espinosa MA; Hansen FO; Andersen KB; Just MK; Fedorova TD; Skjærbæk C; Munk OL; Hansen KV; Gottrup H; Hansen AK; Grothe MJ; Borghammer P
Neuroimage; 2023 Apr; 269():119908. PubMed ID: 36720436
[TBL] [Abstract][Full Text] [Related]
5. Quantification of brain cholinergic denervation in Alzheimer's disease using PET imaging with [
Aghourian M; Legault-Denis C; Soucy JP; Rosa-Neto P; Gauthier S; Kostikov A; Gravel P; Bédard MA
Mol Psychiatry; 2017 Nov; 22(11):1531-1538. PubMed ID: 28894304
[No Abstract] [Full Text] [Related]
6. PET imaging of cholinergic deficits in rats using [18F]fluoroethoxybenzovesamicol ([18F]FEOBV).
Parent M; Bedard MA; Aliaga A; Soucy JP; Landry St-Pierre E; Cyr M; Kostikov A; Schirrmacher E; Massarweh G; Rosa-Neto P
Neuroimage; 2012 Aug; 62(1):555-61. PubMed ID: 22555071
[TBL] [Abstract][Full Text] [Related]
7. Effect of Dopamine D
Schildt A; de Vries EFJ; Willemsen ATM; Giacobbo BL; Moraga-Amaro R; Sijbesma JWA; van Waarde A; Sossi V; Dierckx RAJO; Doorduin J
Mol Pharm; 2020 Mar; 17(3):865-872. PubMed ID: 32011892
[TBL] [Abstract][Full Text] [Related]
8. [18F]fluoroethoxy-benzovesamicol, a PET radiotracer for the vesicular acetylcholine transporter and cholinergic synapses.
Mulholland GK; Wieland DM; Kilbourn MR; Frey KA; Sherman PS; Carey JE; Kuhl DE
Synapse; 1998 Nov; 30(3):263-74. PubMed ID: 9776130
[TBL] [Abstract][Full Text] [Related]
9. Regional vesicular acetylcholine transporter distribution in human brain: A [
Albin RL; Bohnen NI; Muller MLTM; Dauer WT; Sarter M; Frey KA; Koeppe RA
J Comp Neurol; 2018 Dec; 526(17):2884-2897. PubMed ID: 30255936
[TBL] [Abstract][Full Text] [Related]
10. PET imaging with [¹⁸F]fluoroethoxybenzovesamicol ([¹⁸F]FEOBV) following selective lesion of cholinergic pedunculopontine tegmental neurons in rat.
Cyr M; Parent MJ; Mechawar N; Rosa-Neto P; Soucy JP; Aliaga A; Kostikov A; Maclaren DA; Clark SD; Bedard MA
Nucl Med Biol; 2014 Jan; 41(1):96-101. PubMed ID: 24267056
[TBL] [Abstract][Full Text] [Related]
11. No Dopamine Agonist Modulation of Brain [
Albin RL; Kanel P; van Laar T; van der Zee S; Roytman S; Koeppe RA; Scott PJH; Bohnen NI
Mol Pharm; 2022 Apr; 19(4):1176-1182. PubMed ID: 35289620
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography imaging of (2R,3R)-5-[(18)F]fluoroethoxybenzovesamicol in rat and monkey brain: a radioligand for the vesicular acetylcholine transporter.
Kilbourn MR; Hockley B; Lee L; Sherman P; Quesada C; Frey KA; Koeppe RA
Nucl Med Biol; 2009 Jul; 36(5):489-93. PubMed ID: 19520289
[TBL] [Abstract][Full Text] [Related]
13. Modeling of [
Schildt A; de Vries EFJ; Willemsen ATM; Moraga-Amaro R; Lima-Giacobbo B; Sijbesma JWA; Sossi V; Dierckx RAJO; Doorduin J
Mol Imaging Biol; 2020 Aug; 22(4):931-939. PubMed ID: 31907846
[TBL] [Abstract][Full Text] [Related]
14. PET radioligands for the vesicular acetylcholine transporter (VAChT).
Giboureau N; Som IM; Boucher-Arnold A; Guilloteau D; Kassiou M
Curr Top Med Chem; 2010; 10(15):1569-83. PubMed ID: 20583990
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of a new vesamicol analog o-[(11)C]methyl-trans-decalinvesamicol as a PET ligand for the vesicular acetylcholine transporter.
Kitamura Y; Kozaka T; Miwa D; Uno I; Azim MA; Ogawa K; Taki J; Kinuya S; Shiba K
Ann Nucl Med; 2016 Feb; 30(2):122-9. PubMed ID: 26608176
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological characterization of a promising F-18 PET tracer for vesicular acetylcholine transporter.
Tu Z; Zhang X; Jin H; Yue X; Padakanti PK; Yu L; Liu H; Flores HP; Kaneshige K; Parsons SM; Perlmutter JS
Bioorg Med Chem; 2015 Aug; 23(15):4699-4709. PubMed ID: 26138195
[TBL] [Abstract][Full Text] [Related]
17. Kinetics modeling and occupancy studies of a novel C-11 PET tracer for VAChT in nonhuman primates.
Jin H; Zhang X; Yue X; Liu H; Li J; Yang H; Flores H; Su Y; Parsons SM; Perlmutter JS; Tu Z
Nucl Med Biol; 2016 Feb; 43(2):131-9. PubMed ID: 26872437
[TBL] [Abstract][Full Text] [Related]
18. The impact of dopamine D
Liu H; Luo Z; Gu J; Su Y; Flores H; Parsons SM; Zhou Y; Perlmutter JS; Tu Z
Eur J Pharm Sci; 2020 Feb; 143():105152. PubMed ID: 31740395
[TBL] [Abstract][Full Text] [Related]
19. Brain cholinergic alterations in idiopathic REM sleep behaviour disorder: a PET imaging study with
Bedard MA; Aghourian M; Legault-Denis C; Postuma RB; Soucy JP; Gagnon JF; Pelletier A; Montplaisir J
Sleep Med; 2019 Jun; 58():35-41. PubMed ID: 31078078
[TBL] [Abstract][Full Text] [Related]
20. PET Imaging of Cholinergic Neurotransmission in Neurodegenerative Disorders.
Tiepolt S; Meyer PM; Patt M; Deuther-Conrad W; Hesse S; Barthel H; Sabri O
J Nucl Med; 2022 Jun; 63(Suppl 1):33S-44S. PubMed ID: 35649648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
